Central Nervous System Lymphoma Harboring the JAK2 V617F Mutation That Developed after a 20-year History of Polycythemia Vera

Intern Med. 2018 Nov 15;57(22):3293-3297. doi: 10.2169/internalmedicine.1093-18. Epub 2018 Jul 6.

Abstract

A 78-year-old man who had a 20-year history of polycythemia vera (PV) with a JAK2 V617F mutation presented with gradually progressive disturbance of consciousness. Hyper-intense lesions in the peri-lateral ventricular area and left cerebellar hemisphere were observed by T2-weighted and fluid-attenuated inversion recovery magnetic resonance imaging. Cytologic and genetic analyses of the lymphoma cells obtained from his cerebrospinal fluid established the diagnosis of B-cell lymphoma. No lesions outside of the brain were recognized. Because of his poor general condition, he was not treated actively. A postmortem analysis revealed a JAK2 V617F mutation in the lymphoma cells, suggesting their origin was a PV clone.

Keywords: B-cell lymphoma; JAK2 V617F mutation; polycythemia vera; primary central nervous system lymphoma.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Biopsy
  • Central Nervous System Neoplasms / diagnosis
  • Central Nervous System Neoplasms / etiology
  • Central Nervous System Neoplasms / genetics*
  • DNA Mutational Analysis
  • DNA, Neoplasm / genetics*
  • Fatal Outcome
  • Humans
  • Janus Kinase 2 / genetics*
  • Janus Kinase 2 / metabolism
  • Lymphoma / diagnosis
  • Lymphoma / etiology
  • Lymphoma / genetics*
  • Magnetic Resonance Imaging
  • Male
  • Mutation*
  • Polycythemia Vera / complications*
  • Polycythemia Vera / diagnosis
  • Time Factors
  • Tomography, X-Ray Computed

Substances

  • DNA, Neoplasm
  • JAK2 protein, human
  • Janus Kinase 2